{"title":"PET Imaging of Solid Tumors with a G-Quadruplex-Targeting 18F-Labeled Peptide Probe","authors":"Xiao-Chun Guo, Da-Zhi Shi, Shun Huang, Yi-Han Zhang, Wan-Ying Zhang, Jing Chen, Zebin Huang, Hubing Wu, Jin-Qiang Hou, Fu-Jun Jin, Xiu-Cai Chen, Wing-Leung Wong, Yu-Jing Lu","doi":"10.1021/acs.jmedchem.4c02121","DOIUrl":null,"url":null,"abstract":"Positron emission tomography (PET) is a common imaging technique and can provide accurate information about the size, shape, and location of tumors. Recent evidence has shown that G-quadruplex structures (G4s) are identified in human oncogenes, and these special structures are recognized as diagnostic cancer markers and drug targets for anticancer therapies. Although a number of techniques for in vivo imaging of G4s have been developed, achieving sufficient sensitivity and selectivity in vivo remains challenging. Herein, we have engineered and developed a radiolabeled peptide probe [<sup>18</sup>F]AlF-NOTA-RHAU18 targeting mitochondrial DNA G4s for in vivo PET imaging. The results of the study indicate that this probe is able to visualize and detect solid tumors in living homozygous mice. In addition, the distribution of the probe in cancer cells was investigated using FITC-RHAU18. This work may offer new insights into the development of cancer diagnostic tools by targeting in vivo G4s.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"11 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02121","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Positron emission tomography (PET) is a common imaging technique and can provide accurate information about the size, shape, and location of tumors. Recent evidence has shown that G-quadruplex structures (G4s) are identified in human oncogenes, and these special structures are recognized as diagnostic cancer markers and drug targets for anticancer therapies. Although a number of techniques for in vivo imaging of G4s have been developed, achieving sufficient sensitivity and selectivity in vivo remains challenging. Herein, we have engineered and developed a radiolabeled peptide probe [18F]AlF-NOTA-RHAU18 targeting mitochondrial DNA G4s for in vivo PET imaging. The results of the study indicate that this probe is able to visualize and detect solid tumors in living homozygous mice. In addition, the distribution of the probe in cancer cells was investigated using FITC-RHAU18. This work may offer new insights into the development of cancer diagnostic tools by targeting in vivo G4s.
正电子发射断层扫描(PET)是一种常见的成像技术,可提供有关肿瘤大小、形状和位置的准确信息。最近的证据表明,在人类癌基因中发现了 G 型四叠体结构(G4s),这些特殊结构被认为是诊断癌症的标志物和抗癌疗法的药物靶点。虽然已经开发出了许多用于 G4s 体内成像的技术,但要在体内实现足够的灵敏度和选择性仍然具有挑战性。在此,我们设计并开发了一种针对线粒体 DNA G4s 的放射性标记肽探针 [18F]AlF-NOTA-RHAU18,用于体内 PET 成像。研究结果表明,该探针能够在活体同种小鼠体内观察和检测实体瘤。此外,还利用 FITC-RHAU18 研究了探针在癌细胞中的分布情况。这项工作可能会为开发针对体内 G4 的癌症诊断工具提供新的见解。
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.